(NASDAQ: ARAY) Accuray's forecast annual revenue growth rate of -1.19% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.09%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.84%.
Accuray's revenue in 2025 is $465,251,000.On average, 2 Wall Street analysts forecast ARAY's revenue for 2025 to be $46,912,295,074, with the lowest ARAY revenue forecast at $46,850,487,043, and the highest ARAY revenue forecast at $46,974,103,104. On average, 2 Wall Street analysts forecast ARAY's revenue for 2026 to be $46,629,008,268, with the lowest ARAY revenue forecast at $44,903,534,086, and the highest ARAY revenue forecast at $48,354,482,450.
In 2027, ARAY is forecast to generate $46,912,295,074 in revenue, with the lowest revenue forecast at $46,912,295,074 and the highest revenue forecast at $46,912,295,074.